GNCA News and Press, Genocea Biosciences Inc. From 06/18/19

Genocea Biosciences (NASDAQ: GNCA ) down  5.1%  AH, as the company commenced public offering of 10M. More news on: Genocea Biosciences, Inc., Healthcare stocks news, Read more ...

CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. All t...

INSYS Therapeutics (NASDAQ: INSY )  -63%  on filing  Chapter 11 for bankruptcy. More news on: INSYS Therapeutics, Inc., Spark Therapeutics, Inc., Genocea Biosciences, Inc., Stocks on the move, Read more ...

Genocea Biosciences (NASDAQ: GNCA ) is 8.4% lower postmarket after filing to offer up to $50M worth of stock. More news on: Genocea Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Genocea Biosciences ( GNCA ) presented some outstanding immunogenicity data at the American Society for Clinical Oncology ((ASCO)) 2019 medical meeting. It highlighted initial data from its phase 1/2a study using its neoantigen vaccine GEN-009. While this was just immunogenicity data, it was...

Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...

Risk comes from not knowing what you're doing. - Warren Buffett In researching a lead for Integrated BioSci Investing members, I uncovered an interesting vaccine innovator known as Genocea Biosciences ( GNCA ). Due to the company's robust data presented at the 2019 Annual Meeting of the ...

Gainers:  ReWalk Robotics (NASDAQ: RWLK ) +126% . Genocea Biosciences (NASDAQ: GNCA ) +14% . Dean Foods (NYSE: DF ) +13% . RAVE Restaurant Group (NASDAQ: RAVE ) +11% . Medley Management (NYSE: MDLY ) +10% . Neon Therapeutics (NASDAQ: NTGN ) +10% . Allena Pharmaceuticals (NASDAQ:...

Vislink Technologies (NASDAQ: VISL ) -25% . More news on: Vislink Technologies, Inc., Box, Inc., Alexco Resource Corp., Stocks on the move, Read more ...

Investment thesis Genocea Biosciences ( GNCA ) is a clinical-stage biopharmaceutical initially focused on vaccine development for herpes simplex virus-2 (HSV2) and Streptococcus pneumoniae or pneumococcus, using antigen discovery platform ATLAS. Clinical studies for HSV2 demonstrated some ef...